Characteristics | n (%) | PIAS3 | P valuea | |
---|---|---|---|---|
C ≦ N | C > N | |||
Stage | 0.064 | |||
 I | 30 (30.0) | 14 | 16 | |
 II | 44 (44.0) | 28 | 16 | |
 III | 26 (26.0) | 20 | 6 | |
Estrogen receptor status | 0.852 | |||
 Negative | 38 (38.0) | 24 | 14 | |
 Positive | 62 (62.0) | 38 | 24 | |
Progesterone receptor status | 0.843 | |||
 Negative | 54 (54.0) | 33 | 21 | |
 Positive | 46 (46.0) | 29 | 17 | |
Her2/Neu statusb | 0.193 | |||
 Negative | 34 (35.1) | 24 | 10 | |
 Positive | 63 (64.9) | 36 | 27 | |
Lymph node metastasis status | 0.071 | |||
 Absent | 49 (49.0) | 26 | 23 | |
 Present | 51 (51.0) | 36 | 15 |